NASDAQ · Financial Statements

Innovative Eyewear, Inc. (LUCY) Revenue, Earnings & Financial Statements

$0.77 NASDAQ: LUCY Market Cap $6.73M

Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Innovative Eyewear, Inc. most recently reported annual revenue of $3.0M, a net loss of $8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Innovative Eyewear, Inc.: net profit was positive in 0 of 7 reported years; operating margin moved from -2269.8% to -319.2%, a shift of +1950.6 percentage points; the most recent year shows a net loss of $8.0M.

Income Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Revenue$0$0$1.0M$1.0M$1.0M$2.0M$3.0M
Operating Expenses$0$1.0M$4.0M$6.0M$8.0M$10.0M$11.0M
Operating Profit$0−$1.0M−$3.0M−$6.0M−$7.0M−$8.0M−$8.0M
Operating Margin-2269.8%-1145.7%-464.1%-845.2%-594.9%-484.2%-319.2%
Other Income$0$0$0$0$0$0$1.0M
Interest$0$0$0$0$0$0$0
Depreciation$0$0$0$0$0$0$0
Profit Before Tax$0−$1.0M−$3.0M−$6.0M−$7.0M−$8.0M−$8.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit$0−$1.0M−$3.0M−$6.0M−$7.0M−$8.0M−$8.0M
EPS−$2.64−$5.19−$12.37−$17.41−$12.67−$5.19−$1.90

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricDec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Revenue$1.0M$0$0$0$1.0M$0$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Operating Expenses$3.0M$2.0M$2.0M$2.0M$3.0M$2.0M$3.0M$3.0M$3.0M$3.0M$3.0M$3.0M
Operating Profit−$3.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M
Operating Margin-412.6%-525.4%-639.6%-694.8%-314.6%-418.9%-374.8%-287.5%-260.4%-306.6%-168.7%-231.6%
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M−$2.0M
EPS−$3.70−$3.04−$1.87−$0.99−$0.87−$0.72−$0.66−$0.38−$0.34−$0.37−$0.26−$0.27

Over the 7 years reported for Innovative Eyewear, Inc., cash stood at $7.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 9.00 times.

Balance Sheet — 7 Years (USD millions)

Metric2019202020212022202320242025
Total Assets$0$0$1.0M$5.0M$6.0M$10.0M$10.0M
Current Assets$0$0$1.0M$4.0M$6.0M$9.0M$9.0M
Cash$0$0$0$4.0M$4.0M$3.0M$7.0M
Inventory$0$0$0$0$1.0M$1.0M$2.0M
Receivables$0$0$0$0$0$0$0
Fixed Assets$0$0$0$0$0$0$0
Capital Work in Progress$0$0$0$0$0$0$0
Investments$0$0$0$0$0$5.0M$0
Other Assets$0$0$0$0$0$0$0
Total Liabilities$0$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Current Liabilities$0$1.0M$1.0M$1.0M$1.0M$1.0M$1.0M
Borrowings$0$1.0M$0$0$0$0$0
Other Liabilities$0$0$0$1.0M$1.0M$1.0M$1.0M
Equity$0$0$0$0$0$0$0
Reserves$0−$1.0M$0$4.0M$6.0M$9.0M$9.0M

For Innovative Eyewear, Inc., operating cash flow was positive in 0 of 7 reported years; free cash flow in the latest year was negative at $8.0M; free cash flow was positive in 0 of 7 years.

Cash Flow Statement — 7 Years (USD millions)

Metric2019202020212022202320242025
Operating Cash Flow$0$0−$1.0M−$3.0M−$6.0M−$7.0M−$7.0M
Investing Cash Flow$0$0$0$0$0−$5.0M$4.0M
Financing Cash Flow$0$0$0$0$3.0M$4.0M$0
Net Cash Flow$0$0$0$4.0M$1.0M−$2.0M$4.0M
Free Cash Flow$0$0−$1.0M−$3.0M−$6.0M−$7.0M−$8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.48
FCF Yield-106.29%
Quick Ratio8.64
Interest Coverage—
Return 1Y-47.87%
Return 3Y-90.60%
Return 5Y—

Innovative Eyewear, Inc. (LUCY) financials — frequently asked questions

What is Innovative Eyewear, Inc.'s annual revenue?

Innovative Eyewear, Inc. (LUCY) reported annual revenue of $3.0M in its most recent fiscal year.

What is Innovative Eyewear, Inc.'s net profit?

Innovative Eyewear, Inc. (LUCY) reported a net loss of $8.0M in its most recent fiscal year.

What is LUCY EV/EBITDA?

Innovative Eyewear, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.48. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Medical - Instruments & Supplies stocks

BDX revenue $19.5BMDLN stockWST revenue $3.1BSOLV revenue $8.3BBAX revenue $11.2BCOO revenue $4.1BRGEN revenue $738.0MAVTR revenue $6.6BATR revenue $3.8BBLCO revenue $5.1BAll Medical - Instruments & Supplies stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
LUCY Overview LUCY Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.